Predicting Prostate Cancer Risk: Is PRS Testing Ready? : vim

Despite its promise, PRS testing is not routine. The central debate about PRS lies in whether the risk score can predict who will develop prostate cancer that needs to be treated and who won't.

Related Keywords

Ann Arbor , Michigan , United States , Chicago , Illinois , New York , Cambridge , Cambridgeshire , United Kingdom , American , Todd Morgan , William Catalona , Giordano Botta , Aroon Hingorani , Sowmiya Moorthie , Eric Klein , Burcu Darst , University College London , Fred Hutchinson Cancer Center , Polygenic Risk Score Company , University Of Alabama At Birmingham , Northwestern University Feinberg School Of Medicine , Cambridge University , University Of Michigan , Northwestern University Feinberg School , Cleveland Clinic , Penn Medicine , Prostate Carcinoma , Alignant Prostate Neoplasm , Prostate Cancer , Ancer Prostate , Cancer , Alignant Neoplasia , Arcinoma , Prostatic , Cancer Risk , Genomics , Genomic Medicine , Edicine Genomic , Biologic Therapy , Leukemia , Prostate Specific Antigen Psa , Prostate Specific Antigen , Sa , Genetics , Primary Care , Tumor ,